Design Medical, Inc. to Present at Medtech Insight and Windhover Information's ``In3 Medical Device Summit'' Conference, June 21-23, 2006, in San Francisco.

SAN FRANCISCO -- Design Medical, Inc. has announced that it will be presenting on Thursday, June 22, at 11:00 AM at Medtech Insight and Windhover Information's "In3 Medical Device Summit" Conference, June 21-23, 2006, at The Palace Hotel in San Francisco.

Design Medical announced it is in discussions with financial and strategic partners to further development of its prototype heart pump, developed for use in cardiopulmonary bypass (CPB) surgery. Already approved for animal studies, the pump is being prepared for trials. Design Medical is an early stage medical device company that has developed a revolutionary heart pump that can reduce complications following heart surgery. Current pumping technologies are a frequent cause of renal and neurological complications, failing to push blood through up to 40% of the capillaries, thereby causing organ damage, especially in the kidneys.

The Design Medical pump achieves superior flow and pressure performance, mimicking the physiological performance of the human heart -- something no other pump does -- in a proprietary, economical, and robust package. Currently, pumps used in CPB are continuous flow and are incapable of delivering the impulse energy required to supply blood flow to critical organs. The few blood pumps from non-CPB applications that offer pressure-sensitive pulsatility are extremely expensive, unreliable, or noisy and typically require constant clinician monitoring. The Design Medical pumping system comprises a reusable driver and a high-margin disposable that is used only once per each surgery. The result is better patient care and improved perfusion throughout all organs, thus reducing the negative complications of heart surgery, while passing on substantial savings to the hospital.

Currently there are 400,000 patients treated per year in the U.S. alone. Acute kidney failure occurs in over 5% of CPB surgeries and each incidence costs the hospitals $100,000 above the typical capitated reimbursement rate. The addressable savings opportunity is $2-6 billion per year. Technology has allowed many patients to delay surgery with a stent that holds the blocked arteries open. However, even advances in drug-coated stents do not cure the underlying disease, and eventually surgery is the only option. Market size will be positively impacted by a number of other trends, including major demographic shifts to an older population, increased obesity, and diabetes, and increased wealth in Second and Third World areas. The company's patent-pending technology was developed internally with angel investments and founders' funds.

Contact Doug Vincent, President & CEO, 70 Bridge St. #8, Pelham, NH 03076-3419, Tel/Fax [phone] (or 978-805-3412), [e-mail].

A division of Windhover Information Inc., Medtech Insight is the leading provider of business information and market intelligence for the medical technology marketplace. The In3 Medical Device Summit (www.meddevicesummit.com) is Medtech Insight's 21st investment and partnering event to date. To register to attend or for more information on Medtech Insight, please call Kristy Grimes at 480-985-9512 or 888-202-5939 toll-free in the U.S., e-mail [e-mail], or visit www.medtechinsight.com.